A recent study reported an average A1C change among individuals with type 2 diabetes using basal insulin or noninsulin therapies of −3.0 ± 1.3% ( 13 ), a highly significant and clinically meaningful change.
← all excerpts
The Dexcom Community Glucose Monitoring Project: 6-Month Results Using Continuous Glucose Monitoring in Type 2 Diabetes.
1
—
—